The Foundation for Vaccines GAVI announced today an agreement with the American pharmaceutical company modern by which 100 million doses of anticovid vaccines adapted to the new variants will be offered at the lowest price on the market to low-income countries in 2023.
The agreement “is a great step forward for equitable access, to help the program COVAX to adjust their stocks to demand and to ensure that low-income countries have access to appropriate vaccines,” said the CEO of GAVISeth Berkeley, in a statement.
The agreement also implies canceling the shipments that were still pending for 2022, in order to offer vaccines more adapted to the evolution of the pandemic.
The program COVAXin which the World Health Organization (WHO)has distributed 1.8 billion anticovid vaccines (186 million Moderna) in 146 countries around the world, which represents “the largest and fastest distribution in public health in history”, according to GAVI.
This effort, underlines the organization, has allowed 92 low-income countries, many of them in Africa but also in Asia and Latin America, to protect an average of 50% of their populations against covid-19.
MORE NEWS:
EFE International news agency based in Madrid and present in more than 110 countries.